Medico Remedies Intrinsic Value
Medico Remedies (MEDICO) median intrinsic value is ₹39.87 from 9 valuation models (range ₹25–₹98), vs current price ₹48.96 — -18.6% downside (Trading Above Median Value), margin of safety -22.8%. Browse MEDICO financial statements for revenue, profit, balance sheet and cash flow data.
MEDICO Valuation Methods Summary — DCF, Graham Number & P/E
Medico Remedies intrinsic value across 9 models vs current price ₹48.96 — upside/downside and value range per method. Also explore MEDICO share price data to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹34.76 | ₹27.81 - ₹41.71 | -29.0% | EPS: ₹1.58, Sector P/E: 22x |
| Book Value Method | asset | ₹89.41 | ₹80.47 - ₹98.35 | +82.6% | Book Value/Share: ₹44.71, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹97.92 | ₹88.13 - ₹107.71 | +100.0% | Revenue/Share: ₹121.18, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹97.92 | ₹88.13 - ₹107.71 | +100.0% | EBITDA: ₹17.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹27.31 | ₹21.85 - ₹32.77 | -44.2% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹25.28 | ₹22.75 - ₹27.81 | -48.4% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹25.33 | ₹22.80 - ₹27.86 | -48.3% | Revenue Growth: 13.8%, Adj P/E: 16.0x |
| ROE Based Valuation | profitability | ₹97.92 | ₹88.13 - ₹107.71 | +100.0% | ROE: 17.1%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹39.87 | ₹35.88 - ₹43.86 | -18.6% | EPS: ₹1.58, BVPS: ₹44.71 |
MEDICO Intrinsic Value vs Market Price — All Valuation Models
Medico Remedies fair value range ₹25–₹98 vs current market price ₹48.96 across 9 valuation models. For current market price and key ratios, visit Medico Remedies share price screener.
MEDICO Intrinsic Value Analysis — Undervalued or Overvalued?
Medico Remedies median intrinsic value ₹39.87, current price ₹48.96 — Trading Above Median Value by 18.6%, margin of safety -22.8%.
What is the intrinsic value of MEDICO?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Medico Remedies (MEDICO) is ₹39.87 (median value). With the current market price of ₹48.96, this represents a -18.6% variance from our estimated fair value.
The valuation range spans from ₹25.28 to ₹97.92, indicating ₹25.28 - ₹97.92.
Is MEDICO undervalued or overvalued?
Based on our multi-method analysis, Medico Remedies (MEDICO) appears to be trading above median value by approximately 18.6%.
MEDICO Financial Health — Key Ratios vs Industry Benchmarks
Medico Remedies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 17.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.35x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
MEDICO Cash Flow Quality — Operating & Free Cash Flow
Medico Remedies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹8 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-11 Cr | ₹-20 Cr | Negative Cash Flow | 3/10 |